These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38885622)

  • 1. Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999-2018.
    Nguyen BT; Nguyen VH; Le M; Henry L; Cheung R; Nguyen MH
    Dig Dis; 2024; 42(5):473-485. PubMed ID: 38885622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
    Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
    Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States.
    Golovaty I; Tien PC; Price JC; Sheira L; Seligman H; Weiser SD
    J Nutr; 2020 Jan; 150(1):91-98. PubMed ID: 31504710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Stepanova M; Rafiq N; Younossi ZM
    Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia, healthy living, and mortality in patients with chronic liver diseases.
    Van Dongen C; Paik JM; Harring M; Younossi Y; Price JK; Kabbara K; Golabi P; Younossi ZM
    Hepatol Commun; 2022 Nov; 6(11):3140-3153. PubMed ID: 35950286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of chronic liver disease in individuals with human immunodeficiency virus infection.
    Rafiq N; Stepanova M; Lam B; Nader F; Srishord M; Younossi ZM
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):60-4. PubMed ID: 24378267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
    Hirode G; Saab S; Wong RJ
    JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.
    Setiawan VW; Stram DO; Porcel J; Lu SC; Le Marchand L; Noureddin M
    Hepatology; 2016 Dec; 64(6):1969-1977. PubMed ID: 27301913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Parity in Patients with Chronic Liver Disease.
    Golabi P; Fazel S; Otgonsuren M; Escheik C; Sayiner M; Younossi ZM
    Ann Hepatol; 2018 Oct; 17(6):1035-1041. PubMed ID: 30600295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past exposure to hepatitis B: a risk factor for increase in mortality?
    Jinjuvadia R; Liangpunsakul S; Antaki F
    J Clin Gastroenterol; 2014 Mar; 48(3):267-71. PubMed ID: 23751854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in adult all-cause and cause-specific mortality among us adults: mediating and moderating factors.
    Beydoun MA; Beydoun HA; Mode N; Dore GA; Canas JA; Eid SM; Zonderman AB
    BMC Public Health; 2016 Oct; 16(1):1113. PubMed ID: 27770781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival.
    Innes H; Morling JR; Aspinall EA; Goldberg DJ; Hutchinson SJ; Guha IN
    Public Health; 2020 Oct; 187():165-171. PubMed ID: 32992162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017.
    Park SH; Plank LD; Suk KT; Park YE; Lee J; Choi JH; Heo NY; Park J; Kim TO; Moon YS; Kim HK; Jang HJ; Park HY; Kim DJ
    Clin Mol Hepatol; 2020 Apr; 26(2):209-215. PubMed ID: 31679316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle.
    Major JM; Sargent JD; Graubard BI; Carlos HA; Hollenbeck AR; Altekruse SF; Freedman ND; McGlynn KA
    Ann Epidemiol; 2014 Feb; 24(2):104-10. PubMed ID: 24332863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
    Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
    Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
    Doycheva I; Watt KD; Rifai G; Abou Mrad R; Lopez R; Zein NN; Carey WD; Alkhouri N
    Dig Dis Sci; 2017 May; 62(5):1373-1380. PubMed ID: 28194666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb-
    Jing J; Wang RL; Zhao XY; Zhu Y; Niu M; Wang LF; Song XA; He TT; Sun YQ; Xu WT; Yu SM; Wang LP; Guo YM; Bai ZF; Xiao XH; Wang JB
    BMJ Open; 2019 Jan; 9(1):e023567. PubMed ID: 30782709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Cotter TG; Mitchell MC; Patel MJ; Anouti A; Lieber SR; Rich NE; Arab JP; Díaz LA; Louissaint J; Kerr T; Mufti AR; Hanish SI; Vagefi PA; Patel MS; VanWagner LB; Lee WM; O'Leary JG; Singal AG
    Transplantation; 2024 Jan; 108(1):225-234. PubMed ID: 37340542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.